期刊文献+

小儿IgA肾病血管内皮细胞生长因子及其受体的表达

Pediatric IgA Nephropathy Ascular Endothelial Growth Factor and Its Receptor Expression
在线阅读 下载PDF
导出
摘要 目的探讨IgA肾病患儿肾组织中血管内皮细胞生长因子(VEGF)及其受体VEGF2R2(flk21)表达,并将其表达水平与临床病理改变进行相关性分析。方法免疫组织化学SP法。结果肾小球内VEGF和flk21在中度病变组肾小球内表达最多,重度病变组表达最少,两组相比较,差异具有统计学意义(P<0.05)。轻、中度病变组肾小球内VEGF表达与尿蛋白含量呈正相关(P<0.05)。肾小球VEGF表达与肾小球微血管密度呈正相关(P<0.05),重度病变组肾小球微血管密度明显减少(P<0.05)。结论本研究表明VEGF在小儿IgA肾病的发病进展过程中起着重要作用,其作用机制有细胞外基质合成增多、内皮细胞通透性增强、血管生成障碍等。 Objective To explore the children in the kidney tissues IgA nephropathy vascular endothelial growth factor(VEGF) and its receptor VEGF2R2(flk21) expressing,and its expression level and the relevant analysis of clinical pathological changes.Methods Immunohistochemical SP method.Results In flk21 glomerular inside VEGF and moderate lesions group most,severe glomerular expressed in the least,two lesions group expression compared,differences of a statistically significant(P0.05).Light,medium lesions group within the glomerulus with urinary protein content express VEGF positively related(P0.05).Glomerular VEGF expression and positively correlated glomerular capillary density(P0.05),adanced lesions glomerular microvessel density significantly reduce group(P0.05).Conclusion This study shows that VEGF the onset of pediatric IgA nephropathy in progress plays an important role in the process,and its mechanism have extracellular matrix synthesis increase,endothelial cells permeability increase,angiogenesis,obstacles and so on.
作者 朱伟峰
出处 《中国医药指南》 2011年第16期49-50,共2页 Guide of China Medicine
关键词 血管内皮细胞生长因子 IGA肾病 小儿 Vascular endothelial growth factor IgA nephropathy Children
  • 相关文献

参考文献6

二级参考文献64

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:400
  • 2肖厚勤 ,张建鄂 ,丁国华 ,张永 ,张庆红 ,李涛 ,罗昌霞 .糖尿病肾病患者尿中结缔组织生长因子的检测及意义[J].临床内科杂志,2004,21(8):527-529. 被引量:7
  • 3刘志红,黎磊石.葡萄球菌肠毒素诱发的IgA肾病模型[J].中华肾脏病杂志,1989,5(1):6-10. 被引量:72
  • 4汤颖,娄探奇,成彩联,彭晖,关伟明.实验性IgA肾病模型的改进[J].中山大学学报(医学科学版),2006,27(2):184-187. 被引量:110
  • 5Nair R, Walker PD. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA [ J ]. Kidney Int, 2006,69 ( 8 ) : 1455-1458.
  • 6Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattraetant protein-1 in human-cultured mesangial cells [ J ]. J Biol Chem, 2002,277 : 20309 -20315.
  • 7Matsummoto K, Kanmatsuse K. Elevated vascular endothelial growth facor levels in the urine ofpatientswithminimal-change nephrotic syndrome [ J ]. Clin Nephrol, 2001,55 ( 4 ) : 269-274.
  • 8Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial growth factor activatesMAP kinase and enhances collagen synthesis in human mesangial cells [J]. Kidney Int, 1999,56 (6) :2055-2063.
  • 9DALLA M, MASIERO A, ROITER AM, et al. Is podocyte injury relevantin diabetic nephropathy? Studies in patients with type 2 diabetes[J]. Diabetes, 2003, 52: 1031-1035.
  • 10ASANUMA K, MUNDEL P. The role of podocytes in glomerular patho-biology[J]. Clin Exp Nephrol, 2003, 7: 255-259.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部